Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.

Svob Strac D, Pivac N, Smolders IJ, Fogel WA, De Deurwaerdere P, Di Giovanni G.

Front Neurosci. 2016 Nov 10;10:492. eCollection 2016. Review.

2.

A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.

Wolff A, Joshi RK, Ekström J, Aframian D, Pedersen AM, Proctor G, Narayana N, Villa A, Sia YW, Aliko A, McGowan R, Kerr AR, Jensen SB, Vissink A, Dawes C.

Drugs R D. 2017 Mar;17(1):1-28. doi: 10.1007/s40268-016-0153-9. Review.

3.

Treatment of major depressive disorders with generic duloxetine and paroxetine: a multi-centered, double-blind, double-dummy, randomized controlled clinical trial.

Wang Z, Xu X, Tan Q, Li K, Ma C, Xie S, Gao C, Wang G, Li H.

Shanghai Arch Psychiatry. 2015 Aug 25;27(4):228-36. doi: 10.11919/j.issn.1002-0829.215064.

4.

Reduction of patient-reported antidepressant side effects, by type of collaborative care.

Hudson TJ, Fortney JC, Pyne JM, Lu L, Mittal D.

Psychiatr Serv. 2015 Mar 1;66(3):272-8. doi: 10.1176/appi.ps.201300570. Epub 2014 Dec 1.

5.

Duloxetine in affective disorders: a naturalistic study on psychiatric and medical comorbidity, use in association and tolerability across different age groups.

Dell'osso B, Camuri G, Dobrea C, Buoli M, Serati M, Altamura AC.

Clin Pract Epidemiol Ment Health. 2012;8:120-5. doi: 10.2174/1745017901208010120. Epub 2012 Nov 2.

6.

Developmental influence of the serotonin transporter on the expression of npas4 and GABAergic markers: modulation by antidepressant treatment.

Guidotti G, Calabrese F, Auletta F, Olivier J, Racagni G, Homberg J, Riva MA.

Neuropsychopharmacology. 2012 Feb;37(3):746-58. doi: 10.1038/npp.2011.252. Epub 2011 Oct 19. Erratum in: Neuropsychopharmacology. 2012 Apr;37(5):1322.

7.

Evidence for a differential opioidergic involvement in the analgesic effect of antidepressants: prediction for efficacy in animal models of neuropathic pain?

Wattiez AS, Libert F, Privat AM, Loiodice S, Fialip J, Eschalier A, Courteix C.

Br J Pharmacol. 2011 Jun;163(4):792-803. doi: 10.1111/j.1476-5381.2011.01297.x.

8.

Synthesis and structure-activity studies of benzyl ester meperidine and normeperidine derivatives as selective serotonin transporter ligands.

Gu X, Izenwasser S, Wade D, Housman A, Gulasey G, Rhoden JB, Savoie CD, Mobley DL, Lomenzo SA, Trudell ML.

Bioorg Med Chem. 2010 Dec 1;18(23):8356-64. doi: 10.1016/j.bmc.2010.09.060. Epub 2010 Sep 29.

9.

Synthesis and monoamine transporter affinity of 3alpha-arylmethoxy-3beta-arylnortropanes.

Kaur H, Izenwasser S, Verma A, Wade D, Housman A, Stevens ED, Mobley DL, Trudell ML.

Bioorg Med Chem Lett. 2009 Dec 15;19(24):6865-8. doi: 10.1016/j.bmcl.2009.10.087. Epub 2009 Oct 23.

Supplemental Content

Support Center